Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophagitis | 4 | 2021 | 164 | 1.840 |
Why?
|
Liver Neoplasms | 13 | 2022 | 4317 | 1.820 |
Why?
|
Hamartoma | 3 | 2022 | 235 | 1.620 |
Why?
|
Liver | 13 | 2022 | 7527 | 1.410 |
Why?
|
Choristoma | 3 | 2021 | 206 | 1.400 |
Why?
|
Adenoma, Liver Cell | 2 | 2020 | 32 | 1.370 |
Why?
|
Hypertension, Portal | 3 | 2023 | 226 | 1.370 |
Why?
|
Carcinoma, Hepatocellular | 9 | 2022 | 2297 | 1.310 |
Why?
|
Gastritis | 2 | 2019 | 199 | 1.080 |
Why?
|
Barrett Esophagus | 2 | 2020 | 492 | 1.060 |
Why?
|
Hepatitis, Autoimmune | 2 | 2019 | 172 | 1.020 |
Why?
|
Liver Diseases | 4 | 2024 | 1297 | 1.020 |
Why?
|
Hepatic Veins | 1 | 2024 | 112 | 0.910 |
Why?
|
Hepatitis B, Chronic | 3 | 2017 | 410 | 0.900 |
Why?
|
Alagille Syndrome | 2 | 2022 | 45 | 0.870 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 73 | 0.820 |
Why?
|
Gastric Mucosa | 3 | 2021 | 604 | 0.800 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2022 | 38 | 0.790 |
Why?
|
Esophagus | 2 | 2019 | 1033 | 0.770 |
Why?
|
Tongue Diseases | 1 | 2021 | 68 | 0.740 |
Why?
|
Skin Diseases | 2 | 2022 | 1094 | 0.740 |
Why?
|
Hemangiosarcoma | 1 | 2023 | 215 | 0.730 |
Why?
|
Choledochal Cyst | 1 | 2020 | 25 | 0.720 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1032 | 0.710 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2020 | 55 | 0.700 |
Why?
|
Liver Failure, Acute | 1 | 2022 | 181 | 0.700 |
Why?
|
Biopsy | 10 | 2022 | 6766 | 0.680 |
Why?
|
Diagnosis, Differential | 13 | 2024 | 12973 | 0.680 |
Why?
|
Lymphocytes | 2 | 2019 | 2612 | 0.680 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 190 | 0.680 |
Why?
|
Colon, Transverse | 1 | 2019 | 24 | 0.670 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2019 | 59 | 0.660 |
Why?
|
Bladder Exstrophy | 1 | 2020 | 106 | 0.660 |
Why?
|
Duodenitis | 1 | 2019 | 20 | 0.660 |
Why?
|
Gingival Neoplasms | 1 | 2019 | 20 | 0.660 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2019 | 12 | 0.660 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2019 | 41 | 0.650 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 129 | 0.650 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.640 |
Why?
|
Colitis, Ulcerative | 3 | 2021 | 1922 | 0.640 |
Why?
|
Jejunal Diseases | 1 | 2019 | 46 | 0.640 |
Why?
|
Intestinal Atresia | 1 | 2019 | 68 | 0.640 |
Why?
|
Polyps | 1 | 2020 | 200 | 0.640 |
Why?
|
Awards and Prizes | 1 | 2023 | 360 | 0.620 |
Why?
|
Inflammatory Bowel Diseases | 4 | 2023 | 2422 | 0.580 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 296 | 0.580 |
Why?
|
Jejunum | 1 | 2019 | 472 | 0.560 |
Why?
|
Granuloma, Pyogenic | 1 | 2017 | 47 | 0.560 |
Why?
|
Hemangioendothelioma | 1 | 2017 | 111 | 0.540 |
Why?
|
Liver Transplantation | 4 | 2022 | 2330 | 0.540 |
Why?
|
Submandibular Gland Diseases | 1 | 2016 | 22 | 0.540 |
Why?
|
Histiocytes | 1 | 2016 | 98 | 0.530 |
Why?
|
Neck | 1 | 2021 | 734 | 0.530 |
Why?
|
Antiviral Agents | 2 | 2019 | 3060 | 0.530 |
Why?
|
Esophageal Motility Disorders | 1 | 2016 | 49 | 0.530 |
Why?
|
Candidiasis | 1 | 2019 | 365 | 0.530 |
Why?
|
Sialadenitis | 1 | 2016 | 45 | 0.520 |
Why?
|
Pigmentation | 1 | 2016 | 144 | 0.520 |
Why?
|
Cysts | 1 | 2021 | 681 | 0.520 |
Why?
|
Vascular Diseases | 1 | 2024 | 1161 | 0.510 |
Why?
|
Budd-Chiari Syndrome | 1 | 2015 | 24 | 0.510 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2015 | 49 | 0.500 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2015 | 29 | 0.500 |
Why?
|
Vascular Malformations | 1 | 2021 | 468 | 0.500 |
Why?
|
Colonoscopy | 2 | 2021 | 1394 | 0.490 |
Why?
|
Head | 1 | 2021 | 924 | 0.490 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2014 | 23 | 0.480 |
Why?
|
Metaplasia | 3 | 2020 | 322 | 0.470 |
Why?
|
Colonic Polyps | 1 | 2019 | 554 | 0.470 |
Why?
|
Adenovirus Infections, Human | 1 | 2014 | 73 | 0.460 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 833 | 0.460 |
Why?
|
Hepatitis, Viral, Human | 1 | 2014 | 141 | 0.460 |
Why?
|
Child | 25 | 2024 | 80157 | 0.460 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 296 | 0.450 |
Why?
|
Sarcoma, Kaposi | 1 | 2017 | 374 | 0.450 |
Why?
|
Polycythemia Vera | 1 | 2015 | 161 | 0.440 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 819 | 0.410 |
Why?
|
Biliary Atresia | 1 | 2022 | 88 | 0.390 |
Why?
|
Humans | 67 | 2024 | 761578 | 0.360 |
Why?
|
Varicose Veins | 1 | 2022 | 155 | 0.350 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2020 | 75 | 0.350 |
Why?
|
Esophageal and Gastric Varices | 1 | 2022 | 208 | 0.340 |
Why?
|
Cholangiocarcinoma | 1 | 2015 | 552 | 0.340 |
Why?
|
Bile Duct Neoplasms | 1 | 2015 | 605 | 0.340 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2827 | 0.340 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 491 | 0.340 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2020 | 112 | 0.330 |
Why?
|
Immunocompromised Host | 1 | 2014 | 858 | 0.320 |
Why?
|
Pediatrics | 1 | 2024 | 3589 | 0.320 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2020 | 174 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3639 | 0.310 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 1768 | 0.300 |
Why?
|
Esophagogastric Junction | 2 | 2020 | 347 | 0.300 |
Why?
|
Bone and Bones | 1 | 2018 | 2568 | 0.290 |
Why?
|
Male | 37 | 2024 | 360841 | 0.280 |
Why?
|
Endothelial Cells | 3 | 2023 | 3549 | 0.270 |
Why?
|
Adolescent | 17 | 2024 | 88323 | 0.260 |
Why?
|
beta Catenin | 3 | 2020 | 1040 | 0.260 |
Why?
|
Hemangioma | 2 | 2024 | 727 | 0.260 |
Why?
|
Female | 36 | 2024 | 392688 | 0.230 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4544 | 0.230 |
Why?
|
Infant | 10 | 2024 | 36193 | 0.230 |
Why?
|
Prognosis | 8 | 2022 | 29629 | 0.230 |
Why?
|
Education, Graduate | 1 | 2024 | 75 | 0.220 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.220 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1200 | 0.220 |
Why?
|
Calmodulin | 1 | 2024 | 218 | 0.220 |
Why?
|
Sarcoma | 1 | 2015 | 1801 | 0.220 |
Why?
|
Lymphangioma | 1 | 2023 | 61 | 0.210 |
Why?
|
Skin | 1 | 2017 | 4484 | 0.210 |
Why?
|
Sweet Syndrome | 1 | 2023 | 58 | 0.210 |
Why?
|
Leukoplakia, Oral | 1 | 2023 | 77 | 0.210 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2024 | 169 | 0.200 |
Why?
|
Immunohistochemistry | 5 | 2024 | 11076 | 0.200 |
Why?
|
Horner Syndrome | 1 | 2022 | 36 | 0.200 |
Why?
|
Dystrophin | 1 | 2023 | 283 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 1 | 2024 | 461 | 0.190 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 42 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 72 | 0.180 |
Why?
|
Activating Transcription Factor 1 | 1 | 2020 | 26 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 267 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 180 | 0.180 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 94 | 0.180 |
Why?
|
Transgenes | 1 | 2023 | 1010 | 0.170 |
Why?
|
Duodenal Diseases | 1 | 2020 | 100 | 0.170 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2020 | 101 | 0.170 |
Why?
|
Umbilical Cord | 1 | 2021 | 177 | 0.170 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2020 | 100 | 0.170 |
Why?
|
Cholestasis | 1 | 2022 | 378 | 0.170 |
Why?
|
Lymphocytosis | 1 | 2020 | 121 | 0.170 |
Why?
|
Pathology, Surgical | 1 | 2020 | 151 | 0.170 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9420 | 0.160 |
Why?
|
Infant, Newborn | 5 | 2023 | 26198 | 0.160 |
Why?
|
Scalp | 1 | 2022 | 389 | 0.160 |
Why?
|
Fetal Death | 1 | 2021 | 435 | 0.160 |
Why?
|
Middle Aged | 19 | 2024 | 220917 | 0.160 |
Why?
|
RNA-Binding Protein EWS | 1 | 2020 | 210 | 0.160 |
Why?
|
Chromogranins | 1 | 2019 | 161 | 0.160 |
Why?
|
Spores, Fungal | 1 | 2019 | 90 | 0.160 |
Why?
|
Gallbladder | 1 | 2020 | 308 | 0.160 |
Why?
|
Th1 Cells | 2 | 2021 | 1036 | 0.150 |
Why?
|
Tongue | 1 | 2021 | 403 | 0.150 |
Why?
|
Child, Preschool | 7 | 2024 | 42231 | 0.150 |
Why?
|
Intestinal Mucosa | 2 | 2019 | 3032 | 0.150 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 177 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 2 | 2021 | 4514 | 0.150 |
Why?
|
Candida | 1 | 2019 | 172 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 502 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 195 | 0.150 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 392 | 0.150 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 68 | 0.150 |
Why?
|
Gene Fusion | 1 | 2020 | 356 | 0.140 |
Why?
|
Spleen | 1 | 2023 | 2295 | 0.140 |
Why?
|
Esophagoscopy | 1 | 2019 | 396 | 0.140 |
Why?
|
Fluorenes | 1 | 2018 | 157 | 0.140 |
Why?
|
Epithelium | 1 | 2021 | 1603 | 0.140 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2022 | 617 | 0.130 |
Why?
|
Ribavirin | 1 | 2018 | 395 | 0.130 |
Why?
|
Maxilla | 1 | 2019 | 494 | 0.130 |
Why?
|
Malacoplakia | 1 | 2015 | 14 | 0.130 |
Why?
|
Retrospective Studies | 12 | 2023 | 80646 | 0.130 |
Why?
|
Eosinophilia | 1 | 2020 | 560 | 0.130 |
Why?
|
Transaminases | 1 | 2016 | 199 | 0.130 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1668 | 0.130 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 768 | 0.130 |
Why?
|
Histology | 1 | 2015 | 16 | 0.120 |
Why?
|
Hepatectomy | 1 | 2019 | 557 | 0.120 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 415 | 0.120 |
Why?
|
Aged | 13 | 2024 | 169308 | 0.120 |
Why?
|
Lymphocyte Count | 1 | 2016 | 778 | 0.120 |
Why?
|
Telomerase | 1 | 2019 | 745 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1250 | 0.110 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1560 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2017 | 629 | 0.110 |
Why?
|
Pancreas | 1 | 2020 | 1691 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2021 | 0.110 |
Why?
|
Adult | 14 | 2024 | 221200 | 0.110 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 155 | 0.110 |
Why?
|
Gene Silencing | 1 | 2019 | 1509 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13642 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2019 | 874 | 0.100 |
Why?
|
Europe | 1 | 2019 | 3420 | 0.100 |
Why?
|
Benzimidazoles | 1 | 2018 | 858 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1159 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15266 | 0.100 |
Why?
|
Diet, Reducing | 1 | 2014 | 485 | 0.090 |
Why?
|
Mutation | 4 | 2020 | 30054 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39107 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 2986 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.080 |
Why?
|
Preoperative Care | 1 | 2019 | 2242 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2915 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.080 |
Why?
|
Patient Selection | 1 | 2019 | 4244 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2791 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 13510 | 0.070 |
Why?
|
Inflammation | 2 | 2018 | 10774 | 0.070 |
Why?
|
Autoimmunity | 1 | 2014 | 1356 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2015 | 1157 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15843 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3359 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10554 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1116 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4251 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5799 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15732 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18398 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1728 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6346 | 0.050 |
Why?
|
Weight Loss | 1 | 2014 | 2684 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8528 | 0.050 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 60 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 59254 | 0.050 |
Why?
|
Single Umbilical Artery | 1 | 2021 | 3 | 0.050 |
Why?
|
Risk Factors | 2 | 2020 | 74212 | 0.050 |
Why?
|
Diet | 1 | 2019 | 8075 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36426 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2015 | 12794 | 0.040 |
Why?
|
Blood Glucose | 1 | 2014 | 6391 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9031 | 0.040 |
Why?
|
Long QT Syndrome | 1 | 2024 | 467 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12947 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2022 | 696 | 0.040 |
Why?
|
Codon | 1 | 2021 | 601 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2024 | 14417 | 0.040 |
Why?
|
Universities | 1 | 2024 | 993 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 22176 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2023 | 1835 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 523 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7859 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 899 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5821 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 64684 | 0.040 |
Why?
|
Immune Tolerance | 2 | 2017 | 2302 | 0.040 |
Why?
|
Action Potentials | 1 | 2024 | 1834 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5368 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1624 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5841 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1222 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2418 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2391 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2606 | 0.030 |
Why?
|
Animals | 5 | 2024 | 168475 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1517 | 0.030 |
Why?
|
United States | 2 | 2019 | 72335 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58983 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2015 | 5485 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14607 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20099 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9281 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17904 | 0.030 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1860 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8553 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1869 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 726 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1935 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1092 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 3066 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20569 | 0.020 |
Why?
|
Taxoids | 1 | 2014 | 668 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22172 | 0.020 |
Why?
|
Curriculum | 1 | 2024 | 3743 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 646 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1574 | 0.020 |
Why?
|
Chemokines | 1 | 2014 | 959 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2014 | 877 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2014 | 587 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1229 | 0.020 |
Why?
|
Pancreatectomy | 1 | 2014 | 811 | 0.020 |
Why?
|
Antigens | 1 | 2015 | 1443 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 823 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2918 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3429 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4369 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1893 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1603 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3272 | 0.020 |
Why?
|
Th17 Cells | 1 | 2014 | 794 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3449 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1787 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81539 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10451 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2049 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11120 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22173 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54423 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6214 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2014 | 2050 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18255 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3878 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5870 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14665 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7237 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4399 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23447 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9542 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2244 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12953 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21355 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26127 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29876 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9177 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39970 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16592 | 0.010 |
Why?
|
Aging | 1 | 2014 | 8711 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11742 | 0.010 |
Why?
|